Oncotype Dx recurrence score among BRCA1/2 germline mutation carriers with hormone receptors positive breast cancer

Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations

(2016) R. Lewin et al.   BREAST CANCER RESEARCH AND TREATMENT

Neo-adjuvant doxorubicin and cyclophosphamide followed by paclitaxel in triple-negative breast cancer among BRCA1 mutation carriers and non-carriers

(2016) Shani Paluch-Shimon et al.   BREAST CANCER RESEARCH AND TREATMENT

Twenty-one-gene recurrence score assay inBRCA-associated versus sporadic breast cancers: Differences based on germline mutation status

(2016) Payal D. Shah et al.   CANCER

Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast Cancer

(2016) R. Gyanchandani et al.   CLINICAL CANCER RESEARCH

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

(2012) N. Mavaddat et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Response to Neoadjuvant Systemic Therapy for Breast Cancer inBRCAMutation Carriers and Noncarriers: A Single-Institution Experience

(2011) Banu Arun et al.   JOURNAL OF CLINICAL ONCOLOGY

Breast Cancer Prognosis inBRCA1andBRCA2Mutation Carriers: An International Prospective Breast Cancer Family Registry Population-Based Cohort Study

(2011) Pamela J. Goodwin et al.   JOURNAL OF CLINICAL ONCOLOGY